Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology
Disease area: Interstitial lung diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Donato Lacedonia (Molfetta, Italy), Donato Lacedonia, Giovanna E. Carpagnano, Giuseppe Galgano, Piero Schino, Michele Correale, Natale D. Brunetti, Valentina Ventura, Matteo Di Biase, Maria Pia Foschino Barbaro. Usefulness of FVC/DLCO ratio to stratify the risk of mortality in patients with pulmonary hypertension. Eur Respir J 2016; 48: Suppl. 60, 2425

Member's Comments

No comment yet.

Related content which might interest you: NT-proBNP in assessment of pulmonary hypertension in COPD patients Source: Annual Congress 2013 –COPD treatment Year: 2013 Evaluation of FVC/DLCO ratio as a predictor for pulmonary hypertension in patients with interstitial lung diseases Source: International Congress 2017 – ILDs: clinical problems Year: 2017 The prevalence and characteristics of pulmonary hypertension in severe COPD Source: International Congress 2016 – Pulmonary hypertension in lung disease Year: 2016 Prevalence of pulmonary hypertension among COPD patients: screening by echocardiography and NT-PROBNP Source: Annual Congress 2009 - Pulmonary vascular diseases Year: 2009 Cardiopulmonary MR characteristics can estimate mPAP in COPD Source: International Congress 2016 – Pulmonary hypertension: the clinic I Year: 2016 Clinical usefulness of end-tidal CO2 profiles during rapidly-incremental exercise in patients with idiopathic and chronic thromboembolic pulmonary hypertension Source: Annual Congress 2013 –Clinical exercise physiology Year: 2013 Pressure-flow relationship during exercise predicts transplant-free survival in patients with pre-capillary pulmonary hypertension Source: International Congress 2015 – Pulmonary hypertension: new pathophysiological insights Year: 2015 Hemodynamic assessment of patients with pulmonary hypertension due to lung disease and/or hypoxia Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II Year: 2013 CT measured pulmonary artery to aorta ratio as a predictor of pulmonary hypertension in COPD Source: International Congress 2014 – Pulmonary hypertension in lung disease Year: 2014 Co-morbidities and pulmonary arterial hypertension (PAH) in COPD patients Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 Pulmonary hypertension and COPD: Clinical assessment and biomarkers Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II Year: 2013 Lack correlation between FVC/DLC index and pulmonary hypertension in non sclerodermic patients Source: International Congress 2015 – Pulmonary hypertension: management Year: 2015 Prognostic predictors in younger and older incident idiopathic pulmonary arterial hypertension Source: Annual Congress 2013 –Pulmonary circulation: clinical physiology Year: 2013 Incidence and outcomes of haemoptysis in patients with operable and non-operable chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH) Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension Year: 2016 Risk assessment, therapy and cardiovascular comorbidity in patients with pulmonary arterial hypertension Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension Year: 2020 About cardiac output assessment in pulmonary hypertension Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment Year: 2013 Prognostic role of excessive exercise ventilation in non-operable patients with chronic thromboembolic pulmonary hypertension Source: International Congress 2016 – Mechanisms of symptoms and exercise limitation in health and disease Year: 2016 Transthoracic echocardiography does not improve sPESI scale value in low risk pulmonary thromboembolism patients Source: International Congress 2015 – Pulmonary circulation: the story of fresh and old clots Year: 2015 Cardiopulmonary comorbidities are associated with hemodynamics in pulmonary arterial hypertension Source: International Congress 2015 – Pulmonary hypertension: management Year: 2015 Pulmonary hypertension in COPD: Prevalence and characteristics Source: Annual Congress 2012 - COPD comorbidities II Year: 2012